![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.reuters.com/article/us-endo-intl-subpeona/u-s-subpoenas-endo-for-information-on-opioid-painkillers-idUSKBN1F01T3
http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-endo-international-plc---endp-300479173.html
http://www.biospectrumasia.com/news/25/9034/us-fda-requests-endo-pharmaceuticals-to-remove-opana-er-for-risks-related-to-abuse.html
http://www.biospace.com/News/first-time-ever-fda-asks-endo-pharma-to-stop/459477/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.prnewswire.com/news-releases/endo-statement-on-fda-advisory-committees-vote-related-to-opana-er-300423788.html
http://seekingalpha.com/article/4054181-fda-panel-re-examine-opana-er
http://www.prnewswire.com/news-releases/endo-announces-agreement-to-resolve-federal-trade-commission-investigation-and-litigation-300394901.html
http://www.in-pharmatechnologist.com/Drug-Delivery/Grunenthal-says-anti-crush-tech-Endo-uses-for-Opana-ER-helps-prevent-abuse
http://www.pharmatimes.com/news/endo_withdraws_abuse-deterrent_labelling_for_opana_er_1099598
https://www.pharmacompass.com/pdf/news/aurolifes-generic-oxymorphone-hydrochloride-approved-in-us-1462019789.pdf
https://www.statnews.com/pharmalot/2016/03/31/patents-monopoly-antitrust/
http://www.prnewswire.com/news-releases/depomed-acquires-us-rights-to-late-stage-first-in-class-pain-product-from-grunenthal-300180429.html
https://www.pharmacompass.com/pdf/news/suns-generic-oxymorphone-hcl-approved-in-usa-for-moderate-to-severe-pain-1443365933.pdf